Dolby Laboratories (DLB) Projected to Announce Quarterly Earnings on Tuesday

Dolby Laboratories (NYSE:DLB) is anticipated to post its Q4 2026 results after the market closes on Tuesday, November 17th. Analysts expect Dolby Laboratories to post earnings of $1.19 per share and revenue of $372.76 million for the quarter. Parties may visit the company’s upcoming Q4 2026 earnings report for the latest details on the call scheduled for Tuesday, November 17, 2026 at 5:00 PM ET.

Dolby Laboratories Stock Down 0.1%

DLB stock opened at $64.75 on Tuesday. Dolby Laboratories has a 52-week low of $48.26 and a 52-week high of $69.95. The stock has a market cap of $6.07 billion, a price-to-earnings ratio of 27.55 and a beta of 0.79. The business has a fifty day moving average of $60.77 and a two-hundred day moving average of $59.38.

Dolby Laboratories declared that its Board of Directors has approved a stock buyback plan on Thursday, July 30th that allows the company to buy back $350 million in outstanding shares. This repurchase authorization allows the electronics maker to buy up to 7% of its stock through open market purchases. Share repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

Insider Buying and Selling at Dolby Laboratories

In other news, SVP John D. Couling sold 7,667 shares of Dolby Laboratories stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the sale, the senior vice president directly owned 166,803 shares of the company’s stock, valued at approximately $9,804,680.34. The trade was a 4.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the sale, the chief accounting officer directly owned 34,453 shares of the company’s stock, valued at $2,249,091.84. The trade was a 3.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 19,517 shares of company stock valued at $1,184,093 over the last quarter. 37.93% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Weiss Ratings upgraded Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Zacks Research cut shares of Dolby Laboratories from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, August 28th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $87.50.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video.

The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Founded by Ray Dolby in 1965, the company serves customers and partners worldwide.